Oncology Institute Inc (NASDAQ:TOI) has a beta value of 0.24 and has seen 0.62 million shares traded in the recent trading session. The company, currently valued at $94.69M, closed the recent trade at $1.25 per share which meant it gained $0.11 on the day or 9.65% during that session. The TOI stock price is -30.4% off its 52-week high price of $1.63 and 89.6% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.72 million shares traded. The 3-month trading volume is 761.98K shares.
The consensus among analysts is that Oncology Institute Inc (TOI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Oncology Institute Inc (NASDAQ:TOI) trade information
Sporting 9.65% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TOI stock price touched $1.25 or saw a rise of 7.41%. Year-to-date, Oncology Institute Inc shares have moved 304.53%, while the 5-day performance has seen it change -0.79%. Over the past 30 days, the shares of Oncology Institute Inc (NASDAQ:TOI) have changed 72.65%. Short interest in the company has seen 1.1 million shares shorted with days to cover at 2.1.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 84.38% from the levels at last check today. The projected low price target is $6.0 while the price target rests at a high of $10.0. In that case, then, we find that the latest price level in today’s session is -700.0% off the targeted high while a plunge would see the stock gain -380.0% from the levels at last check today.
Oncology Institute Inc (TOI) estimates and forecasts
The company’s shares have gained 303.75% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -488.57% over the past 5 years.
TOI Dividends
Oncology Institute Inc is expected to release its next earnings report on 2024-Aug-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Insiders own 12.89% of the company shares, while shares held by institutions stand at 35.76% with a share float percentage of 41.06%. Investors are also buoyed by the number of investors in a company, with Oncology Institute Inc having a total of 37.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 4.75 million shares worth more than $2.19 million. As of 2024-06-30, FMR LLC held 6.4005% of shares outstanding.
The other major institutional holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with the holding of over 3.36 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.55 million and represent 4.5263% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 1.68% shares in the company for having 1.27 shares of worth $1.59 million while later fund manager owns 422.98 shares of worth $0.53 million as of Dec 31, 2024, which makes it owner of about 0.56% of company’s outstanding stock.
